2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Published:2012-01 Issue:1 Volume:8 Page:63-66
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Azzoli Christopher G.¹,Temin Sarah¹,Giaccone Giuseppe¹

Affiliation:

1. Memorial Sloan-Kettering Cancer Center, New York, NY; American Society of Clinical Oncology, Alexandria, VA; and National Cancer Institute, Bethesda, MD

Abstract

ASCO produced the 2011 Focused Update based on phase III randomized clinical trials published on maintenance chemotherapy, addressing one question from the 2009 Guideline Update on chemotherapy for stage IV NSCLC: what is the optimal duration of first-line chemotherapy for stage IV NSCLC?

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2011.000374

Reference2 articles.

1. American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

2. 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Features and Treatment Patterns of Non-Small Cell Lung Cancer Patients Treated at Tikur Anbessa Specialized Tertiary Hospital in Addis Ababa, Ethiopia: A Retrospective Cross-Sectional Study from 2017 - 2020;2023-06-13

2. Docetaxel Plus Nedaplatin or Carboplatin as Second-Line Chemotherapy for Advanced Lung Squamous Cell Carcinoma in Real-World Practice: A Single-Center Experience;Technology in Cancer Research & Treatment;2023-01

3. Interobserver Variations in Target Delineation in Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma and its Impact on Target Dose Coverage;Technology in Cancer Research & Treatment;2023-01

4. Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells;Stem Cell Research & Therapy;2022-09-24

5. Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials;Current Medical Research and Opinion;2021-03-24